# Zimmer Biomet Holdings, Inc. (ZBH) stock price

URL: https://funkfolio.com/stock/ZBH

> Zimmer Biomet Holdings, Inc. (ZBH) trades at $102.09, is worth $19.32B, is priced at 25.8× earnings and scores 53/100. Valuation, financials and signals.

---

## Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH) is a healthcare company (medical devices) based in the United States. The share price is $102.09, up 0.67% on the day, which values the company at $19.32B. Price as of 17 Nov 2026, 21:43 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $102.09 +0.67% today
- **Market value:** $19.32B
- **P/E ratio:** 25.8× last 12 months
- **Forward P/E:** 11.4×
- **Dividend yield:** 0.95%
- **Funk Score:** 53/100
- **Against its own history:** Below its usual price usual price $128.21
- **200-week average:** $108.09 6% below

Figures as of 17 Nov 2026, 21:43 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Zimmer Biomet Holdings, Inc. in more detail

ZBH trades at 25.8× its last twelve months' earnings, 11.4× next year's expected earnings, 2.3× sales. Measured against its own history, the price is 20% below what its usual multiples would imply ($128.21) — below its usual price. It sits 6% below its 200-week average of $108.09.

Over the last five fiscal years Zimmer Biomet Holdings, Inc. has compounded revenue 6.1% a year, free cash flow 5.4% a year. Its Funk Score is 53 out of 100 (financial strength 3.4, profitability 6.2, growth 5.3, value 6.1, each out of 10).

In its favour: Share count keeps falling; Five straight years of revenue growth.

10 of the superinvestors tracked here hold ZBH, including Harry Burn (2.2% of the portfolio), Bill Nygren (1.5% of the portfolio), Dodge & Cox team (1.1% of the portfolio).

### Superinvestors holding ZBH

10 of the investors tracked here report a position in their latest 13F filing.

- [Harry Burn Sound Shore Management](https://funkfolio.com/gurus/harry-burn) 2.18% of portfolio · $69.8M · trimmed · Q3 2026
- [Bill Nygren Harris Associates (Oakmark)](https://funkfolio.com/gurus/bill-nygren) 1.46% of portfolio · $1.1B · trimmed · Q2 2026
- [Dodge & Cox team Dodge & Cox](https://funkfolio.com/gurus/dodge-and-cox) 1.08% of portfolio · $2B · trimmed · Q3 2026
- [Sarah Ketterer Causeway Capital Management](https://funkfolio.com/gurus/sarah-ketterer) 0.41% of portfolio · $36.7M · trimmed · Q3 2026
- [Louis Bacon Moore Capital Management](https://funkfolio.com/gurus/louis-bacon) 0.30% of portfolio · $10.8M · trimmed · Q3 2026
- [Brandon Haley Holocene Advisors](https://funkfolio.com/gurus/brandon-haley) 0.23% of portfolio · $101.4M · added · Q2 2026
- [Primecap team Primecap Management](https://funkfolio.com/gurus/primecap) 0.21% of portfolio · $337.7M · trimmed · Q3 2026
- [Mario Gabelli GAMCO Investors](https://funkfolio.com/gurus/mario-gabelli) 0.20% of portfolio · $20.6M · added · Q3 2026
- [Ken Griffin Citadel Advisors](https://funkfolio.com/gurus/ken-griffin) 0.17% of portfolio · $299.4M · added · Q2 2026
- [Charles Brandes (founder) Brandes Investment Partners](https://funkfolio.com/gurus/charles-brandes) 0.05% of portfolio · $7.5M · added · Q3 2026

### Health Care companies of similar size

- [Insmed INSM](https://funkfolio.com/stock/INSM)
- [United Therapeutics UTHR](https://funkfolio.com/stock/UTHR)
- [Incyte INCY](https://funkfolio.com/stock/INCY)
- [Viatris VTRS](https://funkfolio.com/stock/VTRS)
- [Tenet Healthcare THC](https://funkfolio.com/stock/THC)
- [BioNTech BNTX](https://funkfolio.com/stock/BNTX)
- [Guardant Health GH](https://funkfolio.com/stock/GH)
- [Alnylam Pharmaceuticals ALNY](https://funkfolio.com/stock/ALNY)
- [Medpace Holdings MEDP](https://funkfolio.com/stock/MEDP)
- [Revvity RVTY](https://funkfolio.com/stock/RVTY)
- [Exelixis EXEL](https://funkfolio.com/stock/EXEL)
- [Charles River Laboratories International CRL](https://funkfolio.com/stock/CRL)

Side by side: [ZBH vs ALNY (Zimmer Biomet Holdings, Inc. vs Alnylam Pharmaceuticals)](https://funkfolio.com/compare/alny-vs-zbh) [ZBH vs GH (Zimmer Biomet Holdings, Inc. vs Guardant Health)](https://funkfolio.com/compare/gh-vs-zbh) [ZBH vs BNTX (Zimmer Biomet Holdings, Inc. vs BioNTech)](https://funkfolio.com/compare/bntx-vs-zbh) [ZBH vs MEDP (Zimmer Biomet Holdings, Inc. vs Medpace Holdings)](https://funkfolio.com/compare/medp-vs-zbh) [ZBH vs THC (Zimmer Biomet Holdings, Inc. vs Tenet Healthcare)](https://funkfolio.com/compare/thc-vs-zbh)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Zimmer Biomet Holdings, Inc. (ZBH): questions and answers

**What is ZBH's P/E ratio?**

Zimmer Biomet Holdings, Inc. trades at 25.8× its last twelve months' earnings and 11.4× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 10.9× to 133.2×, with a median of 23.8×.

**What is ZBH's PEG ratio?**

Zimmer Biomet Holdings, Inc.'s PEG ratio is 2.17 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Zimmer Biomet Holdings, Inc.'s market cap?**

Zimmer Biomet Holdings, Inc. is valued at $19.32B at a share price of $102.09.

**Is ZBH overvalued or undervalued?**

Against its own history, ZBH is below its usual price: the price is 20% below the $128.21 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is ZBH above its 200-week moving average?**

No. ZBH is 5.6% below its 200-week average of $108.09. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Zimmer Biomet Holdings, Inc. growing?**

Over the last five fiscal years Zimmer Biomet Holdings, Inc.'s revenue grew 6.1% a year; over ten years revenue grew 3.2% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Zimmer Biomet Holdings, Inc. (ZBH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ZBH

Underlying data: Yahoo Finance; company filings with the SEC.
